Search PubMed⌕ Search

Biomedical subjects

M Berger

Publications and source records attributed to M Berger.

At least 973 records · Page 54Linked to original sources
PubMed1979

[Neuromuscular manifestation of sarcoidosis (author's transl)].

Three of our own observations of neuromuscular manifestation of sarcoidosis are presented. In two cases, a slowly progredient myopathic syndrome was evident. This syndrome developed in mid-life and showed asymmetrical distribution. In another case, a polyneuropathic syndrome was seen, which mainly affected motor function of the lower extremities. None of these patients had typical findings on chest x-rays. Histological proof of granulomatous alterations of skeletal muscle was the first indication of sarcoidosis. With reference to a further observation, the diagnostical value of muscle biopsy in sarcoidosis without neuromuscular manifestation is discussed.

Aged↗
PubMed1979

[Fiber type disproportion, a subtype of so-called nonprogressive myopathies (author's transl)].

The clinical course, serological, and electromyographic findings, and also histological, histochemical, and electron microscopic abnormalities of two patients with congenital fiber type disproportion, a subtype of the so-called congenital nonprogressive myopathies, are described in this study. Other important subgroups are discussed regarding both variation and overlapping. As these diseases neither belong to the "classical" myopathies nor to the neuropathies, other possible factors such as a distrubed trophic function of the nerve or abnormalities of the reflex arc are under consideration.

Biopsy↗
PubMed1979

Synergistic action of vincristine and adriamycin in the treatment of experimental rat leukemia L5222.

The therapeutic effect of different ratios of a combination of vincristine and Adriamycin was compared to monotherapy with both substances in advanced rat leukemia L5222. The combination therapy proved to by synergistic. In the upper dose range, no additive toxicity was observed. The combination of 25% vincristine plus 75% Adriamycin effected the best results. In a clinically relevant dose range, the superiority of this ratio was observed independent of the application sequence of the two substances and independent of the time interval between the applications within an 11-hr investigation period.

Animals↗
PubMed1979

Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome.

This report concerns two patients with Bartter's syndrome who were treated with propranolol, spironolactone, and potassium supplements. When ibuprofen was added to this regimen, potassium supplements were no longer required. In both patients, plasma renin activity decreased, plasma volumes increased, and a "catch-up" in linear growth ensued. This report confirms others that indicate prostaglandin synthetase inhibitors are a useful adjunct in the therapy of Bartter's syndrome.

Adolescent↗
PubMed1978

[Obesity and cardiovascular risk].

Epidemiological studies on the relationship of obesity, morbidity and mortality revealed the following results: In life insurance studies, excess mortality of obese people was found with more than 30 percent overweight. Mortality was caused by cardiovascular disease and diabetes mellitus. Obesity at issue of the policy in younger age was a greater risk than in the older age group. In prospective studies with long follow-up periods (greater than 16 years) it could be shown that obesity alone was a risk factor for coronary heart disease, the risk being greatest for men and middle aged women. However, the prevalence of accepted risk factors in an obese population is so high that the question whether obesity alone is a risk factor for coronary heart disease is of little interest. The correlations between obesity and risk factors were of minor magnitude; therefore other factors, such as age or HDL-cholesterol, should be considered in the elucidation of the relationship between obesity and coronary heart disease. HDL-cholesterol appears to be a powerful independent protective factor which is diminished in obesity. Despite the fact that studies proving a prolongation of life by treating obesity are not available, the treatment of obesity may be beneficial for the patient by diminishing risk factors.

Adult↗